• Explore /
  • Poster
  • / Safety and efficacy of intraperitoneal paclitaxel plus systemic FOLFOX for gastric cancer with peritoneal metastasis: Phase I results.

Safety and efficacy of intraperitoneal paclitaxel plus systemic FOLFOX for gastric cancer with peritoneal metastasis: Phase I results.

Abstract Poster

Authors

null

So Hyun Kang

Seoul National University Bundang Hospital (Korea, Republic of ), Seongnam-Si, South Korea

So Hyun Kang , Sa-Hong Min , Jin Won Kim , Eunju Lee , Sangjun Lee , Hyeon Jeong Oh , Young Suk Park , Yoon Jin Lee , Ji-Won Kim , Sang-Hoon Ahn , Yun-Suhk Suh , Keun-Wook Lee , Hye Seung Lee , Hyung-Ho Kim

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03618758

DOI

10.1200/JCO.2022.40.4_suppl.309

Abstract #

309

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Shen Zhao

First Author: Xu Yunxiuxiu

First Author: Shintaro Nakano

First Author: Simon Pernot